These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

793 related items for PubMed ID: 17059510

  • 21. Review article: Altering the natural history of Crohn's disease--evidence for and against current therapies.
    Vermeire S, van Assche G, Rutgeerts P.
    Aliment Pharmacol Ther; 2007 Jan 01; 25(1):3-12. PubMed ID: 17229216
    [Abstract] [Full Text] [Related]

  • 22. Infliximab for the treatment of Crohn's disease: efficacy, safety and pharmacoeconomics.
    Feagan BG, Enns R, Fedorak RN, Panaccione R, Paré P, Steinhart AH, Wild G.
    Can J Clin Pharmacol; 2001 Jan 01; 8(4):188-98. PubMed ID: 11743591
    [Abstract] [Full Text] [Related]

  • 23. Medical management of mild to moderate Crohn's disease: evidence-based treatment algorithms for induction and maintenance of remission.
    Sandborn WJ, Feagan BG, Lichtenstein GR.
    Aliment Pharmacol Ther; 2007 Oct 01; 26(7):987-1003. PubMed ID: 17877506
    [Abstract] [Full Text] [Related]

  • 24. Fistulizing Crohn's disease.
    Felley C, Mottet C, Juillerat P, Pittet V, Froehlich F, Vader JP, Michetti P, Gonvers JJ.
    Digestion; 2007 Oct 01; 76(2):109-12. PubMed ID: 18239401
    [Abstract] [Full Text] [Related]

  • 25. Infliximab treatment and prognostic factors for response in patients with Crohn's disease.
    Mendoza JL, García-Paredes J, Cruz Santamaria DM, Lana R, Ramírez Fernández E, Rodríguez Asteaga E, Díaz-Rubio M.
    Rev Esp Enferm Dig; 2002 May 01; 94(5):269-79. PubMed ID: 12474335
    [Abstract] [Full Text] [Related]

  • 26. Type of fistula determines response to infliximab in patients with fistulous Crohn's disease.
    Parsi MA, Lashner BA, Achkar JP, Connor JT, Brzezinski A.
    Am J Gastroenterol; 2004 Mar 01; 99(3):445-9. PubMed ID: 15056083
    [Abstract] [Full Text] [Related]

  • 27. Infliximab in the surgical management of complex fistulating anal Crohn's disease.
    Talbot C, Sagar PM, Johnston MJ, Finan PJ, Burke D.
    Colorectal Dis; 2005 Mar 01; 7(2):164-8. PubMed ID: 15720356
    [Abstract] [Full Text] [Related]

  • 28. Predicting factors of fistula healing and clinical remission after infliximab-based combined therapy for perianal fistulizing Crohn's disease.
    Tougeron D, Savoye G, Savoye-Collet C, Koning E, Michot F, Lerebours E.
    Dig Dis Sci; 2009 Aug 01; 54(8):1746-52. PubMed ID: 19003531
    [Abstract] [Full Text] [Related]

  • 29. Thalidomide in luminal and fistulizing Crohn's disease resistant to standard therapies.
    Plamondon S, Ng SC, Kamm MA.
    Aliment Pharmacol Ther; 2007 Mar 01; 25(5):557-67. PubMed ID: 17305756
    [Abstract] [Full Text] [Related]

  • 30. Crohn's disease of the vulva.
    Andreani SM, Ratnasingham K, Dang HH, Gravante G, Giordano P.
    Int J Surg; 2010 Mar 01; 8(1):2-5. PubMed ID: 19800432
    [Abstract] [Full Text] [Related]

  • 31. An historical overview of the treatment of Crohn's disease: why do we need biological therapies?
    Rutgeerts PJ.
    Rev Gastroenterol Disord; 2004 Mar 01; 4 Suppl 3():S3-9. PubMed ID: 15580150
    [Abstract] [Full Text] [Related]

  • 32. Does infliximab infusion impact results of operative treatment for Crohn's perianal fistulas?
    Gaertner WB, Decanini A, Mellgren A, Lowry AC, Goldberg SM, Madoff RD, Spencer MP.
    Dis Colon Rectum; 2007 Nov 01; 50(11):1754-60. PubMed ID: 17899271
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Recombinant human granulocyte-macrophage colony stimulating factor (sargramostim) as an alternative therapy for fistulizing Crohn's disease.
    Magno P, Jiménez CE, Ortiz Z, Torres EA.
    P R Health Sci J; 2010 Mar 01; 29(1):60-5. PubMed ID: 20222336
    [Abstract] [Full Text] [Related]

  • 35. Treatment of fistulizing Crohn's disease.
    Judge TA, Lichtenstein GR.
    Gastroenterol Clin North Am; 2004 Jun 01; 33(2):421-54, xi-xii. PubMed ID: 15177547
    [Abstract] [Full Text] [Related]

  • 36. Effect of concurrent elemental diet on infliximab treatment for Crohn's disease.
    Tanaka T, Takahama K, Kimura T, Mizuno T, Nagasaka M, Iwata K, Nakano H, Muramatsu M, Takazoe M.
    J Gastroenterol Hepatol; 2006 Jul 01; 21(7):1143-9. PubMed ID: 16824066
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Follow up of Crohn's disease under therapy with hydro-MRI].
    Ganten M, Encke J, Flosdorff P, Grüber-Hoffmann B, Erb G, Hansmann J.
    Radiologe; 2003 Jan 01; 43(1):26-33. PubMed ID: 12552372
    [Abstract] [Full Text] [Related]

  • 39. Metronidazole therapy for Crohn's disease and associated fistulae.
    Jakobovits J, Schuster MM.
    Am J Gastroenterol; 1984 Jul 01; 79(7):533-40. PubMed ID: 6741906
    [Abstract] [Full Text] [Related]

  • 40. Treatment of fistulizing Crohn's disease.
    Lichtenstein GR.
    Gastroenterology; 2000 Oct 01; 119(4):1132-47. PubMed ID: 11040200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 40.